Publications by authors named "Yining Du"

Claim this Profile
L
Letter to the editor: loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studies.
Yining Du, Yuan Liu, Tianjie Zhu

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis.
Yining Du, Sen Gao, Nan Wang

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment.
Yining Du, Jingyuan Zhao, Shuai Li, Hong Yuan

Mol Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet factor 4-derived C15 peptide broadly inhibits enteroviruses by disrupting viral attachment.
Shuai Lv, Congyi Li, Zhichao Pei, Ziwei Hu, Yining Du

J Virol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications.
Yi-Ning Du, Jin-Wei Zhao

J Hepatocell Carcinoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Naval G Daver, Pau Montesinos, Daniel J DeAngelo, Eunice S Wang, Nikolaos Papadantonakis, Yining Du

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the Field of Two-Dimensional Crystal-Based Photodetectors.
Xiaoling Ye, Yining Du, Mingyang Wang, Benqing Liu, Jiangwei Liu

Nanomaterials (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
Debu Tripathy, Sara M Tolaney, Andrew D Seidman, Carey K Anders, Nuhad Ibrahim, Yining Du

JAMA Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intelligent Error Correction of College English Spoken Grammar Based on the GA-MLP-NN Algorithm.
Yining Du

Comput Intell Neurosci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.
Yining Du, John D Cook, J Jack Lee

J Biopharm Stat· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors.
Todd M Bauer, Manish R Patel, Andres Forero-Torres, Thomas J George, Albert Assad, Yining Du

Onco Targets Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation study for evaluating the performance of response-adaptive randomization.
Yining Du, Xuan Wang, J Jack Lee

Contemp Clin Trials· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis